0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gout Therapeutics Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Auto-10L6185
Home | Market Reports | Health| Health Conditions| Arthritis
Global Gout Therapeutics Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Gout Therapeutics Market Research Report 2022

Code: QYRE-Auto-10L6185
Report
August 2022
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global Gout Therapeutics Market
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries.

The global Gout Therapeutics market size is projected to reach US$ 10260 million by 2028, from US$ 4310 million in 2021, at a CAGR of 13.0% during 2022-2028.

Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gout Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gout Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gout Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gout Therapeutics market.
Global Gout Therapeutics Scope and Market Size
Gout Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Gout Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents

Segment by Application

Acute Gout
Chronic Gout

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Takeda Pharmaceutical Company
Novartis
AstraZeneca
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gout Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Colchicine
1.2.5 Urate-Lowering Agents
1.3 Market by Application
1.3.1 Global Gout Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Acute Gout
1.3.3 Chronic Gout
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gout Therapeutics Market Perspective (2017-2028)
2.2 Gout Therapeutics Growth Trends by Region
2.2.1 Gout Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gout Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Gout Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Gout Therapeutics Market Dynamics
2.3.1 Gout Therapeutics Industry Trends
2.3.2 Gout Therapeutics Market Drivers
2.3.3 Gout Therapeutics Market Challenges
2.3.4 Gout Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gout Therapeutics Players by Revenue
3.1.1 Global Top Gout Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Gout Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gout Therapeutics Revenue
3.4 Global Gout Therapeutics Market Concentration Ratio
3.4.1 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gout Therapeutics Revenue in 2021
3.5 Gout Therapeutics Key Players Head office and Area Served
3.6 Key Players Gout Therapeutics Product Solution and Service
3.7 Date of Enter into Gout Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gout Therapeutics Breakdown Data by Type
4.1 Global Gout Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Gout Therapeutics Forecasted Market Size by Type (2023-2028)
5 Gout Therapeutics Breakdown Data by Application
5.1 Global Gout Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Gout Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gout Therapeutics Market Size (2017-2028)
6.2 North America Gout Therapeutics Market Size by Country (2017-2022)
6.3 North America Gout Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Gout Therapeutics Market Size (2017-2028)
7.2 Europe Gout Therapeutics Market Size by Country (2017-2022)
7.3 Europe Gout Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gout Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Gout Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Gout Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Gout Therapeutics Market Size (2017-2028)
9.2 Latin America Gout Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Gout Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gout Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Gout Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Gout Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company
11.1.1 Takeda Pharmaceutical Company Company Detail
11.1.2 Takeda Pharmaceutical Company Business Overview
11.1.3 Takeda Pharmaceutical Company Gout Therapeutics Introduction
11.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2017-2022)
11.1.5 Takeda Pharmaceutical Company Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gout Therapeutics Introduction
11.2.4 Novartis Revenue in Gout Therapeutics Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Gout Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2017-2022)
11.3.5 AstraZeneca Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Gout Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Gout Therapeutics Introduction
11.5.4 Merck Revenue in Gout Therapeutics Business (2017-2022)
11.5.5 Merck Recent Development
11.6 Regeneron Pharmaceuticals
11.6.1 Regeneron Pharmaceuticals Company Detail
11.6.2 Regeneron Pharmaceuticals Business Overview
11.6.3 Regeneron Pharmaceuticals Gout Therapeutics Introduction
11.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2017-2022)
11.6.5 Regeneron Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Gout Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of NSAIDs
    Table 3. Key Players of Corticosteroids
    Table 4. Key Players of Colchicine
    Table 5. Key Players of Urate-Lowering Agents
    Table 6. Global Gout Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gout Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Gout Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Gout Therapeutics Market Share by Region (2017-2022)
    Table 10. Global Gout Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Gout Therapeutics Market Share by Region (2023-2028)
    Table 12. Gout Therapeutics Market Trends
    Table 13. Gout Therapeutics Market Drivers
    Table 14. Gout Therapeutics Market Challenges
    Table 15. Gout Therapeutics Market Restraints
    Table 16. Global Gout Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Gout Therapeutics Market Share by Players (2017-2022)
    Table 18. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2021)
    Table 19. Ranking of Global Top Gout Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Gout Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Gout Therapeutics Product Solution and Service
    Table 23. Date of Enter into Gout Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Gout Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Gout Therapeutics Revenue Market Share by Type (2017-2022)
    Table 27. Global Gout Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Gout Therapeutics Revenue Market Share by Type (2023-2028)
    Table 29. Global Gout Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Gout Therapeutics Revenue Market Share by Application (2017-2022)
    Table 31. Global Gout Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Gout Therapeutics Revenue Market Share by Application (2023-2028)
    Table 33. North America Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Gout Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Gout Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Gout Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Gout Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Takeda Pharmaceutical Company Company Detail
    Table 44. Takeda Pharmaceutical Company Business Overview
    Table 45. Takeda Pharmaceutical Company Gout Therapeutics Product
    Table 46. Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 47. Takeda Pharmaceutical Company Recent Development
    Table 48. Novartis Company Detail
    Table 49. Novartis Business Overview
    Table 50. Novartis Gout Therapeutics Product
    Table 51. Novartis Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 52. Novartis Recent Development
    Table 53. AstraZeneca Company Detail
    Table 54. AstraZeneca Business Overview
    Table 55. AstraZeneca Gout Therapeutics Product
    Table 56. AstraZeneca Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 57. AstraZeneca Recent Development
    Table 58. GlaxoSmithKline Company Detail
    Table 59. GlaxoSmithKline Business Overview
    Table 60. GlaxoSmithKline Gout Therapeutics Product
    Table 61. GlaxoSmithKline Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 62. GlaxoSmithKline Recent Development
    Table 63. Merck Company Detail
    Table 64. Merck Business Overview
    Table 65. Merck Gout Therapeutics Product
    Table 66. Merck Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 67. Merck Recent Development
    Table 68. Regeneron Pharmaceuticals Company Detail
    Table 69. Regeneron Pharmaceuticals Business Overview
    Table 70. Regeneron Pharmaceuticals Gout Therapeutics Product
    Table 71. Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2017-2022) & (US$ Million)
    Table 72. Regeneron Pharmaceuticals Recent Development
    Table 73. Research Programs/Design for This Report
    Table 74. Key Data Information from Secondary Sources
    Table 75. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gout Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. NSAIDs Features
    Figure 3. Corticosteroids Features
    Figure 4. Colchicine Features
    Figure 5. Urate-Lowering Agents Features
    Figure 6. Global Gout Therapeutics Market Share by Application in 2021 & 2028
    Figure 7. Acute Gout Case Studies
    Figure 8. Chronic Gout Case Studies
    Figure 9. Gout Therapeutics Report Years Considered
    Figure 10. Global Gout Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Gout Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Gout Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Gout Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gout Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Gout Therapeutics Revenue in 2021
    Figure 16. North America Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Gout Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gout Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Gout Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Gout Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Gout Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Gout Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Takeda Pharmaceutical Company Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 45. Novartis Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 46. AstraZeneca Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 47. GlaxoSmithKline Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 48. Merck Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 49. Regeneron Pharmaceuticals Revenue Growth Rate in Gout Therapeutics Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS